差價合約是複雜的工具,並且由於槓桿作用而具有快速虧損的高風險。 84% 的散戶投資者賬戶在與該提供商交易差價合約時虧損您應該考慮自己是否了解差價合約的運作方式,以及您是否有能力承擔損失資金的高風險。

掃碼下載 iOS 和安卓 APP

交易 NGM Biopharmaceuticals, Inc. - NGM CFD

12.80
0.47%
  • 概括
  • 曆史數據
  • 活動
  • 收入報表
  • 資産負債表
  • 現金流
  • 所有權
交易條件
價差 0.06
多頭倉位隔夜費用

Long position overnight fee


Margin. Your investment $1,000.00
隔夜費用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00

前往平台
-0.024068%
空頭倉位隔夜費用

Short position overnight fee


Margin. Your investment $1,000.00
隔夜費用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00

前往平台
0.001846%
隔夜費時間 21:00 (UTC)
最小成交量 1
貨幣 USD
保證金 20%
股票交易 United States of America
交易委員會 0%

*Information provided by Capital.com

關鍵數據
前收盤價* 12.88
開盤價* 12.68
1 年變化* -1.32%
日範圍* 12.39 - 12.86
52 周範圍 2.92-18.25
平均交易量(10 天) 421.63K
平均交易量(3 個月) 6.99M
市值 316.70M
市盈率 -100.00K
流通股 82.05M
收入 55.33M
EPS -2.03
股息(收益率 %) N/A
貝塔 1.24
下一個財報發布日期 May 3, 2023

所有數據都是由Refinitiv提供的, 除了標有星號的數據, 這是*由 Capital.com 提供的數據

  • 上週
  • 上個月
  • 去年
  • 過去兩年
  • 最大
  • 每日
  • 每週
  • 每月
日期 關閉 更改 變化 (%) 打開
Jun 29, 2022 12.80 0.07 0.55% 12.73 12.91 12.32
Jun 28, 2022 12.88 -1.09 -7.80% 13.97 14.24 12.50
Jun 27, 2022 14.68 0.38 2.66% 14.30 14.85 14.13
Jun 24, 2022 14.64 1.16 8.61% 13.48 14.73 13.48
Jun 23, 2022 14.06 0.53 3.92% 13.53 14.06 13.52
Jun 22, 2022 13.75 0.28 2.08% 13.47 14.18 13.47
Jun 21, 2022 13.78 0.25 1.85% 13.53 14.19 13.53
Jun 17, 2022 13.58 0.69 5.35% 12.89 13.95 12.87
Jun 16, 2022 12.86 0.30 2.39% 12.56 13.07 12.34
Jun 15, 2022 12.97 0.46 3.68% 12.51 13.10 12.34
Jun 14, 2022 12.51 0.01 0.08% 12.50 12.66 12.17
Jun 13, 2022 12.31 0.02 0.16% 12.29 12.92 12.08
Jun 10, 2022 12.85 0.31 2.47% 12.54 12.98 12.35
Jun 9, 2022 12.82 -0.48 -3.61% 13.30 13.78 12.43
Jun 8, 2022 13.74 -0.14 -1.01% 13.88 14.80 13.47
Jun 7, 2022 14.03 0.15 1.08% 13.88 14.86 13.63
Jun 6, 2022 13.78 -0.55 -3.84% 14.33 14.66 13.55
Jun 3, 2022 14.49 0.91 6.70% 13.58 14.78 13.45
Jun 2, 2022 13.57 0.77 6.02% 12.80 13.59 12.50
Jun 1, 2022 12.99 -0.90 -6.48% 13.89 14.06 12.99

NGM Biopharmaceuticals, Inc. Events

时间(协调世界时) (UTC) 国家 事件
No events scheduled
查看所有活动
  • 年度
  • 每季度
2021 2020 2019 2018 2017
總收入 77.882 87.368 103.544 108.665 77.141
收入 77.882 87.368 103.544 108.665 77.141
總營業費用 198.577 191.201 152.884 112.979 94.566
銷售/一般/行政費用,總計 36.865 27.229 23.631 17.265 14.83
研究與開發 161.712 163.972 129.253 95.714 79.736
營業收入 -120.695 -103.833 -49.34 -4.314 -17.425
利息收入(費用),非經營淨值 0.42 1.939 6.692 3.622 2.358
其他,淨值 -0.06 -0.593 -0.147 0.199 -0.152
稅前淨收入 -120.335 -102.487 -42.795 -0.493 -15.219
稅後淨收入 -120.335 -102.487 -42.795 -0.493 -14.159
未計算非常項目前的淨收益 -120.335 -102.487 -42.795 -0.493 -14.159
淨收入 -120.335 -102.487 -42.795 -0.493 -14.159
普通股股東可獲收益 (不含非經常性項目) -120.335 -102.487 -42.795 -0.493 -14.159
普通股股東可獲收益 (含非經常性項目) -120.335 -102.487 -42.795 -0.493 -14.159
攤薄淨收入 -120.335 -102.487 -42.795 -0.493 -14.159
攤薄後加權平均股 77.0854 68.4754 50.2975 64.9937 64.9937
扣除特別項目的每股攤薄盈利 -1.56106 -1.4967 -0.85084 -0.00759 -0.21785
Dividends per Share - Common Stock Primary Issue 0 0 0
每股正常攤薄盈利 -1.56106 -1.4967 -0.85084 -0.00759 -0.21785
非常規項目總計 0 0
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
總收入 20.948 20.959 18.575 16.773 21.575
收入 20.948 20.959 18.575 16.773 21.575
總營業費用 53.529 48.183 47.581 53.393 49.42
銷售/一般/行政費用,總計 10.723 9.454 8.867 9.823 8.721
研究與開發 42.806 38.729 38.714 43.57 40.699
營業收入 -32.581 -27.224 -29.006 -36.62 -27.845
利息收入(費用),非經營淨值 0.176 0.085 0.106 0.115 0.114
其他,淨值 -0.045 -0.095 0.035 -0.187 0.187
稅前淨收入 -32.45 -27.234 -28.865 -36.692 -27.544
稅後淨收入 -32.45 -27.234 -28.865 -36.692 -27.544
未計算非常項目前的淨收益 -32.45 -27.234 -28.865 -36.692 -27.544
淨收入 -32.45 -27.234 -28.865 -36.692 -27.544
普通股股東可獲收益 (不含非經常性項目) -32.45 -27.234 -28.865 -36.692 -27.544
普通股股東可獲收益 (含非經常性項目) -32.45 -27.234 -28.865 -36.692 -27.544
攤薄淨收入 -32.45 -27.234 -28.865 -36.692 -27.544
攤薄後加權平均股 78.023 77.7871 77.4089 77.0964 76.0341
扣除特別項目的每股攤薄盈利 -0.4159 -0.35011 -0.37289 -0.47592 -0.36226
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常攤薄盈利 -0.4159 -0.35011 -0.37289 -0.47592 -0.36226
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流動資産總額 379.28 308.426 355.248 214.557 175.533
現金和短期投資 366.253 295.156 344.511 206.633 173.685
現金等價物 151.795 147.017 245.598 56.923 25.593
短期投資 214.458 148.139 98.913 149.71 148.092
應收賬款總額,淨額 4.945 6.433 5.206 3.669 0
Prepaid Expenses 8.082 6.837 5.531 4.255 1.848
Total Assets 402.387 329.043 380.403 246.085 248.941
Property/Plant/Equipment, Total - Net 14.116 14.526 19.475 23.893 24.873
Property/Plant/Equipment, Total - Gross 53.084 50.837 49.231 46.093 40.053
Accumulated Depreciation, Total -38.968 -36.311 -29.756 -22.2 -15.18
Long Term Investments 0 45.15
Other Long Term Assets, Total 8.991 6.091 5.68 7.635 3.385
Total Current Liabilities 61.355 42.583 39.718 41.486 36.893
Accounts Payable 5.246 9.663 9.026 5.775 1.892
Accrued Expenses 38.335 29.945 22.991 14.003 11.686
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 17.774 2.975 7.701 21.708 23.315
Total Liabilities 66.74 49 49.684 59.406 75.045
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 5.385 6.417 9.966 17.92 38.152
Total Equity 335.647 280.043 330.719 186.679 173.896
Preferred Stock - Non Redeemable, Net 0 0 294.874 294.874
Common Stock 0.078 0.071 0.067 0.007 0.012
Additional Paid-In Capital 754.664 578.599 526.771 39.258 26.141
Retained Earnings (Accumulated Deficit) -418.966 -298.631 -196.144 -147.193 -146.7
Other Equity, Total -0.129 0.004 0.025 -0.267 -0.431
Total Liabilities & Shareholders’ Equity 402.387 329.043 380.403 246.085 248.941
Total Common Shares Outstanding 77.9627 70.5854 66.9603 64.9937 64.9937
Total Preferred Shares Outstanding 0 0
Accounts Receivable - Trade, Net 0
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流動資産總額 337.622 379.28 395.883 403.129 425.849
現金和短期投資 329.832 366.253 383.429 390.55 412.656
現金等價物 109.872 151.795 145.826 99.403 148.113
短期投資 219.96 214.458 237.603 291.147 264.543
應收賬款總額,淨額 0.103 4.945 4.4 3.586 4.925
Prepaid Expenses 7.687 8.082 8.054 8.993 8.268
Total Assets 359.773 402.387 415.858 423.011 445.541
Property/Plant/Equipment, Total - Net 13.006 14.116 11.452 12.79 13.733
Property/Plant/Equipment, Total - Gross 53.329 53.084 50.195 50.027 51.257
Accumulated Depreciation, Total -40.323 -38.968 -38.743 -37.237 -37.524
Other Long Term Assets, Total 9.145 8.991 8.523 7.092 5.959
Total Current Liabilities 44.563 61.355 57.728 45.043 40.309
Accounts Payable 4.815 5.246 7.632 5.141 7.535
Accrued Expenses 34.631 38.335 34.72 31.891 29.763
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 5.117 17.774 15.376 8.011 3.011
Total Liabilities 48.636 66.74 61.819 49.936 45.964
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 4.073 5.385 4.091 4.893 5.655
Total Equity 311.137 335.647 354.039 373.075 399.577
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.078 0.078 0.078 0.077 0.077
Additional Paid-In Capital 763.152 754.664 745.704 735.86 725.693
Retained Earnings (Accumulated Deficit) -451.416 -418.966 -391.732 -362.867 -326.175
Other Equity, Total -0.677 -0.129 -0.011 0.005 -0.018
Total Liabilities & Shareholders’ Equity 359.773 402.387 415.858 423.011 445.541
Total Common Shares Outstanding 78.087 77.9627 77.6426 77.3072 76.9136
Total Preferred Shares Outstanding 0
  • 年度
  • 每季度
2021 2020 2019 2018 2017
淨收入/起跑線 -120.335 -102.487 -42.795 -0.493 -14.159
經營活動産生的現金 -73.229 -83.496 -41.174 -7.597 -17.413
經營活動産生的現金 6.089 6.555 7.605 7.223 6.441
非現金物品 36.809 16.136 11.956 9.254 8.043
營運資金的變化 4.208 -3.7 -17.94 -23.581 -17.738
投資活動産生的現金 -71.65 -50.998 48.723 38.729 -2.796
資本支出 -1.684 -1.879 -3.489 -5.844 -6.422
其他投資現金流量項目,總計 -69.966 -49.119 52.212 44.573 3.626
融資活動産生的現金 149.657 35.538 180.751 0.198 0.339
股票的發行(報廢),淨額 149.657 36.151 180.751 2.398 0.339
現金淨變化 4.778 -98.956 188.3 31.33 -19.87
融資現金流項目 0 -0.613 -2.2
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -32.45 -120.335 -93.101 -64.236 -27.544
Cash From Operating Activities -35.738 -73.229 -54.894 -45.535 -22.225
Cash From Operating Activities 1.427 6.089 4.61 3.118 1.554
Non-Cash Items 9.273 36.809 26.838 19.465 6.837
Changes in Working Capital -13.988 4.208 6.759 -3.882 -3.072
Cash From Investing Activities -6.853 -71.65 -93.576 -145.88 -117.156
Capital Expenditures -0.285 -1.684 -1.551 -1.355 -0.16
Other Investing Cash Flow Items, Total -6.568 -69.966 -92.025 -144.525 -116.996
Cash From Financing Activities 0.668 149.657 147.279 143.801 140.477
Issuance (Retirement) of Stock, Net 0.668 149.657 147.279 143.801 140.477
Net Change in Cash -41.923 4.778 -1.191 -47.614 1.096
Financing Cash Flow Items 0 0 0
投資者名稱 投資者類型 流通股百分比 持有股份 股份變動 持有日期 換手率
The Column Group LP Venture Capital 22.7718 18683494 546759 2023-01-31 LOW
Merck Sharp & Dohme Corporation Corporation 15.7898 12955016 0 2022-03-10
EcoR1 Capital, LLC Hedge Fund 7.8437 6435518 0 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 5.4651 4483890 589852 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 3.8293 3141842 82877 2022-12-31 LOW
Rieflin (William J L) Individual Investor 3.3814 2774340 1805 2022-03-10 LOW
StepStone Group LP Private Equity 1.9176 1573357 0 2022-12-31 LOW
Chen (Jin-Long) Individual Investor 1.46 1197893 64000 2023-03-02 LOW
Rubric Capital Management LP Hedge Fund 1.0691 877161 0 2022-12-31 MED
Nuveen LLC Pension Fund 0.9236 757753 18943 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.9126 748724 11408 2022-12-31 LOW
Euclidean Capital, L.L.C. Investment Advisor 0.9101 746674 0 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.8587 704551 -151024 2022-12-31 LOW
Jacobs Levy Equity Management, Inc. Investment Advisor/Hedge Fund 0.8532 700034 616659 2022-12-31 MED
Two Sigma Investments, LP Hedge Fund 0.7419 608690 62050 2022-12-31 HIGH
Acadian Asset Management LLC Investment Advisor/Hedge Fund 0.7084 581223 581223 2022-12-31 MED
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.6946 569857 -104611 2022-12-31 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.6677 547865 -239943 2022-12-31 LOW
Boxer Capital, L.L.C. Hedge Fund 0.6094 500000 0 2022-12-31 LOW
Millennium Management LLC Hedge Fund 0.5585 458230 227384 2022-12-31 HIGH

為什麼選擇Capital.com?我們用表現來證明自己。

Capital.com Group

500K+

貿易商

92K+

每月活躍客戶

$53M+

每月投資額

$30M+

每月提取

差價合約交易計算器

如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。

交易佣金
0
  • 1:1
槓桿
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
打開

關閉

做空 做多
Industry: Bio Therapeutic Drugs

333 Oyster Point Blvd
94080-1978

收入報表

  • Annual
  • Quarterly

人們也觀看

Oil - Crude

70.44 Price
+1.050% 1D Chg, %
多頭倉位隔夜費用 -0.0170%
空頭倉位隔夜費用 -0.0050%
隔夜費時間 21:00 (UTC)
價差 0.03

BTC/USD

27,353.35 Price
-2.720% 1D Chg, %
多頭倉位隔夜費用 -0.0616%
空頭倉位隔夜費用 0.0137%
隔夜費時間 21:00 (UTC)
價差 60.00

XRP/USD

0.42 Price
-14.130% 1D Chg, %
多頭倉位隔夜費用 -0.0753%
空頭倉位隔夜費用 0.0069%
隔夜費時間 21:00 (UTC)
價差 0.00338

Gold

1,969.64 Price
+1.580% 1D Chg, %
多頭倉位隔夜費用 -0.0086%
空頭倉位隔夜費用 0.0004%
隔夜費時間 21:00 (UTC)
價差 0.30

還在尋找值得信賴的經紀商?

加入全球 500.000 多名交易者,選擇與 Capital.com 交易

1. 建立並驗證您的賬戶 2. 存入您的第一筆資金 3. 您已準備就緒。開始交易